Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Descriptive Analysis of Clinical Presentation in a Caribbean Hispanic Population with Neuromyelitis Optica Spectrum Disorders (NMO-SD)

Author:Albelo Martinez, Marelisa   Sotomayor Ortiz, Jazmin   Avila-Ornelas, Jose   Alfonso, Gishlaine   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.017  

Author Institution:Neurology Division, Guaynabo, PR  School of Medicine, University of Puerto Rico, San Juan, PR  Neurology Division, San Juan, PR  Neurology Division, Hato Rey, PR  

Comparison of Multiple Sclerosis Patients With or Without Rebound Activity After Fingolimod Cessation: Five-Year Clinical Outcomes

Author:Güleç, Bade   Everest, Elif   Gorkey, Ogeday Derin   Koc, Metehan   Tutuncu, Melih   Saip, Sabahattin   Siva, Aksel   Uygunoglu, Ugur   

Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

Topic:Multiple Sclerosis  

Program Number:P10.017  

Author Institution:Istanbul University Cerrahpasa-Cerrahpasa Medical Faculty, Istanbul, Turkey  

Importance of Bodily Functions in Neuromyelitis Optica Spectrum Disorder from Neurologists’ Perspective

Author:Téllez Lara, Nieves   Gómez, Rocío   Aguado-Valcarcel, Marta   Sepúlveda, María   Cobo-Calvo, Álvaro   Orviz-García, Aida   Díaz Sánchez, María   Boyero, Sabas   Rebollo, Pablo   Maurino, Jorge   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.018  

Author Institution:Hospital Clínico Universitario de Valladolid, Valladolid, Spain  Medical Department, Roche Farma, Madrid, Spain  Hospital Universitario Álvaro Cunqueiro, Vigo, Spain  Hospital Clínic de Barcelona, Barcelona, Spain  Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain  Fundacion Jimenez Diaz, Madrid, Spain  Hospital Universitario Virgen del Rocío, Sevilla, Spain  Hospital Universitario Cruces, Bilbao, Spain  IQVIA, Madrid, Spain  

The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria

Author:Bermel, Robert   Carr, Warner   Chitnis, Tanuja   Dörner, Thomas   Hayama, Koremasa   Hide, Michihiro   Maurer, Marcus   Montalban, Xavier   Sussman, Gordon   Wiendl, Heinz   Dahale, Swapnil   DeLasHeras, Virginia   Haemmerle, Sibylle   Kieseier, Bernd   Lheritier, Karine   Zharkov, Artem   Willi, Roman   Giménez-Arnau, Ana   

Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

Topic:Multiple Sclerosis  

Program Number:P10.018  

Author Institution:Cleveland Clinic, Cleveland, OH  Allergy and Asthma Associates of Southern California, and Southern California Research, Mission Viejo, CA  Brigham and Women's Hospital, Boston, MA  Charite Universitätsmedizin Berlin, Berlin, Germany  Nihon University School of Medicine, Tokyo, Japan  Hiroshima Citizens Hospital, Minami-ku, Japan  Charité - Universitätsmedizin Berlin, Berlin, Germany  Vall Hebron University Hospital-Multiple Sclerosis Centre of Catalonia, Barcelona, Spain  Gordon Sussman Clinical Research Inc., North York, ON, Canada  University of Muenster, Muenster, Germany  IQVIA, Mumbai, India  Novartis Pharma AG, Basel, Switzerland  Novartis, Basel, Switzerland  Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain  

NMOSD Patients Transitioning from Adolescent to Adult Care: A Multi-institutional Database Analysis in the United States

Author:Wright, Melissa   Wong, Ka-Ho   Francis, Trieste   Sorenson, Abigail   Rose, John   Smith, Tammy   Clardy, Stacey   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.019  

Author Institution:University of Utah, Salt Lake City, UT  U of U Neurology Clinic, Salt Lake City, UT  University of California, Berkeley, CA  Imaging and Neurosciences Center, Salt Lake City, UT